NEW YORK (GenomeWeb News) - InforSense said today that it has extended and expanded a license agreement with Cambridge University’s Department of Pathology for four of its software platforms.
Under the agreement, Cambridge has extended its license for the company’s InforSense and BioSense products, and its GenSense and Genome Wide Association Study modules.
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.